Table 2.

Theranostic nanoparticles for thrombotic diseases.

Carrier nanoparticle material	Imaging agent and Imaging modality	Therapeutics/drugs	Target markers	Binding ligand	Ref.
Iron oxide nanoparticles	Iron oxide - MRI	rtPA	N/A	N/A	77
Iron oxide nanoparticles	Iron oxide - SPECT/CT	rtPA	N/A	N/A	78
Iron oxide nanoparticles	Iron oxide - MRI	rtPA	Platelet membrane glycoprotein GP IIb//IIIa	RGD peptides	79
Iron oxide nanoparticles	Iron oxide - MRI/ VT680 - Fluorescence	rtPA	Activated factor XIII	Activated factor XIII sensitive peptide (FXIIIa) GNQEQVSPLTLLKC	85
Perfluorocarbon polymer nanoparticles	Perfluorocarbon - MRI	PPACK	Thrombin	PPACK	88-90
borylbenzyl carbonate nanoparticles	IR780/IR820 - NIR	hydroxybenzyl alcohol (HBA)	Fibrin	GPRPP- pentapeptide	91, 92